LEEDer Group Inc.
8508 North West 66th St.
Miami, Florida 33166 USA

Phone Toll-free: 866.814.0192 or 305.436.5030
Fax Toll-free: 866.818.0373 or 305.436.0086
E-mail Address: orders {at] LEEDerGroup [dot] com

2012-08 PMD Prior Authorization Demonstration Project

KYDEX-PRO

STRONGER

SAFER

LEEDerGroup.com

3. (LG NOTE: this is a succinct notice with direct links to important pages from CGS Administrators, LLC., a Medicare contractor. this notice only refers to CGS’s area, C, however the information applies to all Medicare areas. The CMS Notice can be found-CLICK_HERE)

  • PMD Prior Authorization Demonstration Project (a 3 year project)

CGS Power Mobility Documentation Resources
CMS Signature Requirements
Dear Supplier Letter-Prior Authorization Demonstration Project MLN Matters Article SE1112
Power Mobility Device Face-to-Face Examination Checklist
Power Mobility Devices Denial Help Aid
Prior Authorization Request Coversheet

  • Effective September 1, 2012, the Medicare Fee-For-Service Program is conducting a three-year prior authorization demonstration project for certain Power Mobility Devices (PMD). In Jurisdiction C, this demonstration project applies to beneficiaries permanently residing in North Carolina, Florida or Texas.
  • The prior authorization process under this demonstration is available for PMD orders written on or after September 1, 2012 for the following Healthcare Common Procedure Coding System (HCPCS) codes:
    Group 1 Power Operated Vehicles (K0800 – K0802 and K0812), All Group 1 and Group 2 standard power wheelchairs (K0813 – K0829), All Group 2 complex rehabilitative power wheelchairs (K0835 – K0843), All Group 3 complex rehabilitative power wheelchairs without power options (K0848 – K0855), Pediatric power wheelchairs (K0890 – K0891); and Miscellaneous power wheelchairs (K0898).
  • A Prior Authorization Request (PAR) may be submitted by either the treating physician/practitioner or the supplier. Before sending the request, the submitter should complete a Prior Authorization Request Coversheet (see link above). The PAR must include the following documentation: Completed PAR coversheet, 7-element written order, Treating physician/practitioner face-to-face assessment, Detailed product description, Specialty evaluation (if required by policy); and Other relevant medical documentation.
  • The request may be mailed or faxed as follows:Fax the PAR to: 615-664-5960
    Mail the PAR to: CGSDME Medical Review – Prior Authorization PO Box 24890 Nashville, TN 37202-4890
  • After receipt of all relevant documentation, CGS will review and communicate a decision within 10 business days. The decision letter regarding prior authorization (affirmative or non-affirmative) will be sent to the treating physician/practitioner, the supplier and the Medicare beneficiary. In the event of a non-affirmative decision, the letter will explain why the PAR was not affirmed. The letter will additionally provide a prior authorization tracking number that should be submitted with the PMD claim.
  • Please note that prior authorization is not mandatory. However without a prior authorization decision, if a claim for one of the HCPCS codes listed above is submitted for a beneficiary residing in North Carolina, Florida or Texas, the claim will be stopped for review. At that time, CGS will send the supplier an Additional Documentation Request (ADR) letter and the supplier must respond within 45 days by providing all requested documentation. Additionally, starting December 1, 2012, CMS will assess a 25 percent payment reduction on a supplier’s payable claim when the first claim is not preceded by a PAR.
  • There is an exception to the 25 percent reduction in payment for competitive bidding contract suppliers submitting a payable claim for a beneficiary with a permanent residence in a competitive bidding area. The competitive bid supplier will receive the contractual single payment amount under their contract. These suppliers, however, must adhere to all other requirements of the demonstration.

For additional information concerning the PMD prior authorization demonstration project, please refer to the above web links.